reports
LigaChem Biosciences Inc: 1 director
A director at LigaChem Biosciences Inc bought 940 shares at 71,600.000KRW and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two y...
LegoChem Biosciences Receives US Patent for Its Own Proprietary ADC Pl...
DAEJEON, South Korea--(BUSINESS WIRE)-- LegoChem Biosciences (“LCB”) (KOSDAQ:141080), a biopharmaceutical company focusing on the research & development of ADCs, based in Daejeon South Korea, announced today that the Company was awarded U.S. Patent No. 14517616, entitled “ANTIBODY-ACTIVE AGENT CONJUGATES AND METHODS OF USE.” The patent illustrates the company’s ConjuAllTM technology, LegoChem’s proprietary ADC platform which enables the design of homogeneous plasma stable ADCs with the potential for improved payload de...
LegoChem Biosciences Enters into Research Licensing Agreement with Tak...
DAEJEON, South Korea--(BUSINESS WIRE)-- LegoChem Biosciences (“LCB”) (KOSDAQ:141080), based in Daejeon South Korea, announced today that the Company has entered into a research licensing agreement with Takeda Pharmaceuticals Company Limited (TSE:4502) (”Takeda”) to evaluate next-generation antibody drug conjugate (ADC) candidates. Through this agreement, Takeda will have access to LCB’s proprietary ADC technology, ConjuAllTM. ConjuAllTM is LCB’s proprietary next-generation ADC technology platform. Utilizing a si...
Ford Equity International Rating and Forecast Report
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.